Piroxicam
- TRADE NAME: Antiflog; Apo-Piroxicam; Baxo; Doblexan; Felden; Feldene (Pfizer); Larapam; Nu-Pirox; Rogal; Sotilen; Zunden
- INDICATIONS: Arthritis
- CLASS: Non-steroidal anti-inflammatory (NSAID)
- HALF-LIFE: 50 hours
CLINICALLY IMPORTANT, POTENTIALLY HAZARDOUS INTERACTIONS WITH:
ACE inhibitors, Aspirin, Furosemide, Lithium, Methotrexate, Ritonavir, Warfarin
PREGNANCY CATEGORY: C
NSAIDs may cause an increased risk of serious cardiovascular and gastrointestinal adverse events, which can be fatal. This risk may increase with duration of use.
Elderly patients are at greater risk for serious gastrointestinal events
Please login to see the rest of this drug profile
SKIN
HAIR
NAILS
MUCOSAL
CARDIOVASCULAR
CENTRAL NERVOUS SYSTEM
NEUROMUSCULAR/SKELETAL
GASTROINTESTINAL/HEPATIC
RESPIRATORY
ENDOCRINE/METABOLIC
GENITOURINARY
RENAL
HEMATOLOGIC
OTIC
OCULAR
OTHER
Symbol key
Incidence 
- <1%
- 1-5%
- 5-10%
- 10-15%
- 15-20%
- 20-30%
- >30%
Seriousness
- Hospitalization possible
- Life Threatening
- Fatal
Warnings in other populations
- Breast feeding
- Geriatric
- Pediatric